Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ORPHAN DRUG AMENDMENTS WOULD BE VETOED BY PRESIDENT BUSH, FDA TELLS SENATE; SEN. HATCH SAYS ORPHAN ACT SHOULD NOT BE USED TO REMEDY FINANCIAL ACCESS
Mar 09 1992
•
By
The Pink Sheet
More from Archive
More from Pink Sheet